Cited by 106Obsessive-Compulsive Spectrum DisordersAnxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesPsychoanalysis and Psychopathology Research

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Need for speed: Evaluating slopes of OCD recovery in behavior therapy enhanced with d-cycloserine

Chasson, Gregory S., Buhlmann, Ulrike, Tolin, David F., Rao, Sowmya R., Reese, Hannah E., Rowley, Theresa, Welsh, Kaitlyn S., Wilhelm, Sabine·2010·Behaviour Research and Therapy

DOI 10.1016/j.brat.2010.03.007

Open this paper in CoChat — free account

Abstract

Evidence suggests that the antibiotic d-cycloserine (DCS) enhances the treatment effects of exposure and response prevention (ERP) for Obsessive-Compulsive Disorder (OCD). Further, evidence suggests that the effects of DCS diminish partway through treatment, but it is unclear to what extent. In an effort to evaluate these issues, the current study re-analyzes data from a 10-session randomized controlled trial of ERP+DCS versus ERP+placebo in a sample of 22 adults with OCD. We analyzed repeated-measures mixed models with random slopes and intercepts across different intervals: sessions 1-10, 1-5, and 6-10. The results indicate that the course of ERP was 2.3 times faster over the full 10 sessions for the DCS compared to the placebo group, and nearly six times quicker in the first half of ERP. Further interpretation of the results suggests that DCS does not amplify the effects of ERP, but instead initiates treatment effects sooner in treatment. In addition, DCS does not necessarily lose its effect over repeated use, but instead may exhaust its maximum utility after effectively jump-starting ERP. Ultimately, DCS may provide a means for curtailing treatment costs, decreasing treatment dropout and refusal rates, and enhancing access to care.

Integrity signals

Registry

Crossref · 10.1016/j.brat.2010.03.007

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
Diagnostic and Statistical Manual of Mental Disorders.
Widiger, T. A. (2000) · Oxford University Press eBooks · doi:10.1037/10518-009 · Cited by 19,766
The Yale-Brown Obsessive Compulsive Scale: I. Development, Use, and Reliability
Goodman, W. K. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810110048007 · Cited by 7,712
The Yale-Brown Obsessive Compulsive Scale: II. Validity
Goodman, W. K. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810110054008 · Cited by 2,799
Cognitive Enhancers as Adjuncts to Psychotherapy: Use of D-Cycloserine in Phobic Individuals to Facilitate Extinctionof Fear
Ressler, K. J., Rothbaum, B. O., Tannenbaum, L., Anderson, P., Graap, K., Zimand, E., Hodges, L., & Davis, M. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.11.1136 · Cited by 1,063
Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive–compulsive disorder
Foa, E. B., Liebowitz, M. R., Kozak, M. J., Davies, S., Campeas, R., Franklin, M. E., Huppert, J. D., Kjernisted, K., Rowan, V., Schmidt, A. B., et al. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.1.151 · Cited by 1,048
Cognitive assessment of obsessive-compulsive disorder
(1997) · Behaviour Research and Therapy · doi:10.1016/s0005-7967(97)00017-x · Cited by 963
Augmentation of Exposure Therapy With D-Cycloserine for Social Anxiety Disorder
Hofmann, S. G., Meuret, A. E., Smits, J. A. J., Simon, N. M., Pollack, M. H., Eisenmenger, K., Shiekh, M., & Otto, M. W. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.3.298 · Cited by 560 · cited 7×
“, 2004) and social anxiety disorder (Hofmann et al., 2006). Three studies of DCS and ERP for OCD have been published to date: Kushner et al. (2007), Storch et al. (2007), and Wilhelm et al. (2008). While both the Kushner et al. (2007) and the Storch et al.”
BackgroundResultInfluential
A meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy
Norberg, M. M., Krystal, J. H., & Tolin, D. F. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.01.012 · Cited by 510
Self-citation
Imputation of missing longitudinal data: a comparison of methods
Engels, J. (2003) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(03)00170-7 · Cited by 478

Flagged first, then by citations

Show all 20 references

Sorted by citations

Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders
Katzman, M. A., Bleau, P., Blier, P., Chokka, P., Kjernisted, K., Van Ameringen, M., & the Canadian Anxiety Guidelines Initiative Group on behalf of the Anxiety Disorders Association of Canada/Association Canadienne des troubles anxieux and McGill University (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-s1-s1 · Cited by 1,090
“Adding d-cycloserine may hasten the onset of improvements with ERP, with significant benefits over placebo during the first four or five ERP sessions [698-700], but this effect has not been seen in all studies [701].”
Background
From Pavlov to PTSD: The extinction of conditioned fear in rodents, humans, and anxiety disorders
VanElzakker, M. B., Kathryn Dahlgren, M., Caroline Davis, F., Dubois, S., & Shin, L. M. (2014) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2013.11.014 · Cited by 482
Pharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disorders
Singewald, N., Schmuckermair, C., Whittle, N., Holmes, A., & Ressler, K. J. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.12.004 · Cited by 390
“, 2013c) and OCD [(Chasson et al., 2010; Farrell et al., 2013; Kushner et al., 2007; Storch et al., 2010; Wilhelm et al., 2008) but see (Mataix-Cols et al.”
BackgroundMethod
A Randomized, Double-Blind Evaluation of d -Cycloserine or Alprazolam Combined With Virtual Reality Exposure Therapy for Posttraumatic Stress Disorder in Iraq and Afghanistan War Veterans
Rothbaum, B. O., Price, M., Jovanovic, T., Norrholm, S. D., Gerardi, M., Dunlop, B., Davis, M., Bradley, B., Duncan, E. J., Rizzo, A., et al. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.13121625 · Cited by 388
D-Cycloserine Augmentation of Exposure-Based Cognitive Behavior Therapy for Anxiety, Obsessive-Compulsive, and Posttraumatic Stress Disorders: A Systematic Review and Meta-analysis of Individual Participant Data
Mataix-Cols, D., Fernández de la Cruz, L., Monzani, B., Rosenfield, D., Andersson, E., Pérez-Vigil, A., Frumento, P., de Kleine, R. A., Difede, J., Dunlop, B. W., et al. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2016.3955 · Cited by 288
Self-citation
Psychopharmacological Treatment of Obsessive-Compulsive Disorder (OCD)
CASALE, A. D., Sorice, S., Padovano, A., Simmaco, M., Ferracuti, S., Lamis, D. A., Rapinesi, C., Sani, G., Girardi, P., Kotzalidis, G. D., et al. (2018) · Current Neuropharmacology · doi:10.2174/1570159x16666180813155017 · Cited by 243
A review of the interplay between tuberculosis and mental health
Doherty, A. M., Kelly, J. R., McDonald, C., O’Dywer, A. M., Keane, J., & Cooney, J. M. (2013) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2013.03.018 · Cited by 187
Exposure and response prevention for obsessive-compulsive disorder: A review and new directions
Simpson, H., & Hezel, D. (2019) · Indian Journal of Psychiatry · doi:10.4103/psychiatry.indianjpsychiatry_516_18 · Cited by 161
“[57] However, there were no group differences in symptom improvement by the end of treatment, suggesting that the drug’s utility lies primarily in speeding up treatment response.[58]”
Background
d-Cycloserine as an Augmentation Strategy With Cognitive-Behavioral Therapy for Social Anxiety Disorder
Hofmann, S. G., Smits, J. A. J., Rosenfield, D., Simon, N., Otto, M. W., Meuret, A. E., Marques, L., Fang, A., Tart, C., & Pollack, M. H. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.12070974 · Cited by 121
Does D-cycloserine enhance exposure therapy for anxiety disorders in humans? A meta-analysis
Rodrigues, H., Figueira, I., Lopes, A., Gonçalves, R., Mendlowicz, M. V., Coutinho, E. S. F., & Ventura, P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093519 · Cited by 109
Efficacy of Augmentation of Cognitive Behavior Therapy With Weight-Adjusted d -Cycloserine vs Placebo in Pediatric Obsessive-Compulsive Disorder
Storch, E. A., Wilhelm, S., Sprich, S. E., Henin, A., Micco, J. A., Small, B. J., Mcguire, J. F., Mutch, P. J., Lewin, A. B., Murphy, T. K., et al. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2016.1128 · Cited by 111
Self-citation
Conditioned fear associated phenotypes as robust, translational indices of trauma-, stressor-, and anxiety-related behaviors
Briscione, M. A., Jovanovic, T., & Norrholm, S. D. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00088 · Cited by 105
New Directions in the Cognitive-Behavioral Treatment of OCD: Theory, Research, and Practice
Abramowitz, J. S., Blakey, S. M., Reuman, L., & Buchholz, J. L. (2018) · Behavior Therapy · doi:10.1016/j.beth.2017.09.002 · Cited by 98
Reducing contamination by exposure plus safety behaviour
Rachman, S., Shafran, R., Radomsky, A. S., & Zysk, E. (2011) · Journal of Behavior Therapy and Experimental Psychiatry · doi:10.1016/j.jbtep.2011.02.010 · Cited by 96
DIFFICULT-TO-TREAT PEDIATRIC OBSESSIVE-COMPULSIVE DISORDER: FEASIBILITY AND PRELIMINARY RESULTS OF A RANDOMIZED PILOT TRIAL OF d -CYCLOSERINE-AUGMENTED BEHAVIOR THERAPY
Farrell, L. J., Waters, A. M., Boschen, M. J., Hattingh, L., McConnell, H. W., Oar, E. L., Collings, N., Zimmer‐Gembeck, M. J., Shelton, D., Ollendick, T. H., et al. (2013) · Depression and Anxiety · doi:10.1002/da.22132 · Cited by 98
Augmentation of cognitive and behavioural therapies (CBT) with d-cycloserine for anxiety and related disorders
Ori, R., Amos, T., Bergman, H., Soares‐Weiser, K., Ipser, J., & Stein, D. J. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007803.pub2 · Cited by 104
d-Cycloserine does not improve but might slightly speed up the outcome of in-vivo exposure therapy in patients with severe agoraphobia and panic disorder in a randomized double blind clinical trial
Siegmund, A., Golfels, F., Finck, C., Halisch, A., Räth, D., Plag, J., & Ströhle, A. (2011) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2011.01.020 · Cited by 89
Glutamate-Modulating Drugs as a Potential Therapeutic Strategy in Obsessive-Compulsive Disorder
Marinova, Z., Chuang, D.-M., & Fineberg, N. (2017) · Current Neuropharmacology · doi:10.2174/1570159x15666170320104237 · Cited by 83
Novel Approach to the Role of NMDA Receptors in Traumatic Brain Injury
Shohami, E., & Biegon, A. R. (2014) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/18715273113126660196 · Cited by 80
Enhancement of psychosocial treatment with D-cycloserine: Models, moderators, and future directions
Otto, M. W., Kredlow, M. A., Smits, J. A. J., Hofmann, S. G., Tolin, D. F., de Kleine, R. A., van Minnen, A., Evins, A. E., & Pollack, M. H. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.09.007 · Cited by 70
Self-citation
Cognitive Behavior Therapy for Obsessive-Compulsive and Related Disorders
Lewin, A. B., Wu, M. S., Mcguire, J. F., & Storch, E. A. (2014) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2014.05.002 · Cited by 73
Trends in Psychiatry and Psychotherapy
(2020) · Trends in Psychiatry and Psychotherapy · doi:10.47626/2237-6089 · Cited by 70
RANDOMIZED TRIAL OF D-CYCLOSERINE ENHANCEMENT OF COGNITIVE-BEHAVIORAL THERAPY FOR PANIC DISORDER
Otto, M. W., Pollack, M. H., Dowd, S. M., Hofmann, S. G., Pearlson, G. D., Szuhany, K. L., Gueorguieva, R. V., Krystal, J. H., Simon, N. M., & Tolin, D. F. (2016) · Depression and Anxiety · doi:10.1002/da.22531 · Cited by 69
Self-citation
Social anxiety and posttraumatic stress symptoms: The impact of distressing social events
Carleton, R. N., Peluso, D. L., Collimore, K. C., & Asmundson, G. J. G. (2010) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2010.08.002 · Cited by 67
Intensive residential treatment for severe obsessive-compulsive disorder: Characterizing treatment course and predictors of response
Brennan, B. P., Lee, C., Elias, J. A., Crosby, J. M., Mathes, B. M., André, M., Gironda, C. M., Pope, H. G., Jenike, M. A., Fitzmaurice, G. M., et al. (2014) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2014.05.008 · Cited by 64
Cognitive–behavioural therapy with post-session d-cycloserine augmentation for paediatric obsessive–compulsive disorder: pilot randomised controlled trial
Mataix‐Cols, D., Turner, C. M., Monzani, B. A., Isomura, K., Murphy, C., Krebs, G., & Heyman, I. (2013) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.113.126284 · Cited by 64
d-Cycloserine as an augmentation strategy for cognitive behavioral therapy of anxiety disorders
Hofmann, S. G., Wu, J. Q., & Boettcher, H. (2013) · Biology of Mood & Anxiety Disorders · doi:10.1186/2045-5380-3-11 · Cited by 59
Enhancing exposure therapy for anxiety disorders, obsessive-compulsive disorder and post-traumatic stress disorder
McGuire, J. F., Lewin, A. B., & Storch, E. A. (2014) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2014.934677 · Cited by 57
“[46] identified improvement among participants receiving DCS relative to placebo at the mid-treatment assessment, with post hoc analyses identifying that therapeutic gains were achieved more quickly for participants receiving DCS relative to placebo [54].”
Glutamate drugs and pharmacogenetics of OCD: a pathway-based exploratory approach
Grados, M. A., Specht, M. W., Sung, H.-M., & Fortune, D. (2013) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2013.845553 · Cited by 49
Does d-Cycloserine Augmentation of CBT Improve Therapeutic Homework Compliance for Pediatric Obsessive–Compulsive Disorder?
Park, J. M., Small, B. J., GELLER, D. A., Murphy, T. K., Lewin, A. B., & Storch, E. A. (2013) · Journal of Child and Family Studies · doi:10.1007/s10826-013-9742-1 · Cited by 49
Exposure therapy, D-cycloserine, and functional magnetic resonance imaging in patients with snake phobia: a randomized pilot study.
Nave, A. M., Tolin, D., & Stevens, M. (2012) · Journal of Clinical Psychiatry · doi:10.4088/jcp.11m07564 · Cited by 48
Self-citation
Cue exposure and response prevention with heavy smokers: a laboratory-based randomised placebo-controlled trial examining the effects of D-cycloserine on cue reactivity and attentional bias
Kamboj, S. K., Joye, A., Das, R. K., Gibson, A. J. W., Morgan, C. J. A., & Curran, H. V. (2012) · Psychopharmacology · doi:10.1007/s00213-011-2571-2 · Cited by 44
Bridging the gap: Lessons we have learnt from the merging of psychology and psychiatry for the optimisation of treatments for emotional disorders
Graham, B. M., Callaghan, B. L., & Richardson, R. (2014) · Behaviour Research and Therapy · doi:10.1016/j.brat.2014.07.012 · Cited by 49
The Psychopharmacology of Obsessive-Compulsive Disorder: A Preclinical Roadmap
Szechtman, H., Harvey, B. H., Woody, E. Z., & Hoffman, K. L. (2019) · Pharmacological Reviews · doi:10.1124/pr.119.017772 · Cited by 41
Changes in cue reactivity and attentional bias following experimental cue exposure and response prevention: a laboratory study of the effects of d-cycloserine in heavy drinkers
Kamboj, S. K., Massey-Chase, R. A., Rodney, L., Das, R., Almahdi, B., Curran, H. V., & Morgan, C. J. A. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2254-z · Cited by 39
Lamotrigine Augmentation Versus Placebo in Serotonin Reuptake Inhibitors-Resistant Obsessive-Compulsive Disorder: A Randomized Controlled Trial.
Khalkhali, M., Aram, S., Zarrabi, H., Kafie, M., & Heidarzadeh, A. (2016) · PubMed Central · Cited by 36
D-CYCLOSERINE ENHANCES GENERALIZATION OF FEAR EXTINCTION IN CHILDREN
Byrne, S., Rapee, R. M., Richardson, R., Malhi, G. S., Jones, M., & Hudson, J. L. (2015) · Depression and Anxiety · doi:10.1002/da.22356 · Cited by 33
Role of Glutamatergic System in Obsessive-Compulsive Disorder with Possible Therapeutic Implications
Vlček, P., Polák, J., Brunovský, M., & Horáček, J. (2017) · Pharmacopsychiatry · doi:10.1055/s-0043-118665 · Cited by 32
A HIGH-THROUGHPUT CLINICAL ASSAY FOR TESTING DRUG FACILITATION OF EXPOSURE THERAPY
Rodebaugh, T. L., Levinson, C. A., & Lenze, E. J. (2013) · Depression and Anxiety · doi:10.1002/da.22047 · Cited by 26
Using cognitive enhancers to improve the treatment of anxiety disorders in young people: Examining the potential for D‐cycloserine to augment exposure for child anxiety
Byrne, S., Farrell, L. J., & Rapee, R. M. (2011) · Clinical Psychologist · doi:10.1111/j.1742-9552.2011.00005.x · Cited by 25
Can Cognitive Behavioral Therapy for Anxiety and Depression Be Improved with Pharmacotherapy? A Meta-analysis
Tolin, D. F. (2017) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2017.08.007 · Cited by 25
Self-citation
D-cycloserine in the treatment of posttraumatic stress disorder
Baker, J., Cates, M. E., & Luthin, D. R. (2017) · Mental Health Clinician · doi:10.9740/mhc.2017.03.088 · Cited by 25
CBT-Plus: A meta-analysis of cognitive behavioral therapy augmentation strategies for obsessive-compulsive disorder
Guzick, A. G., Cooke, D. L., Gage, N. A., & McNamara, J. P. H. (2018) · Journal of Obsessive-Compulsive and Related Disorders · doi:10.1016/j.jocrd.2018.07.001 · Cited by 25
Clinical Pharmacology of Comorbid Obsessive–Compulsive Disorder in Tourette Syndrome
Neri, V., & Cardona, F. (2013) · International review of neurobiology · doi:10.1016/b978-0-12-411546-0.00013-5 · Cited by 25
Outcomes of Specialized Residential Treatment for Adults with Obsessive-Compulsive Disorder
Björgvinsson, Þ., HART, A. J., Wetterneck, C. T., Fletcher, T. L., Chasson, G. S., POWELL, D. M., Heffelfinger, S. K., & Stanley, M. A. (2013) · Journal of Psychiatric Practice · doi:10.1097/01.pra.0000435043.21545.60 · Cited by 25
Self-citation
Mediators of Exposure Therapy for Youth Obsessive-Compulsive Disorder: Specificity and Temporal Sequence of Client and Treatment Factors
Chu, B. C., Colognori, D. B., Yang, G., Xie, M., Bergman, R. L., & Piacentini, J. C. (2015) · Behavior Therapy · doi:10.1016/j.beth.2015.01.003 · Cited by 25
d -Cycloserine Addition to Exposure Sessions in the Treatment of Patients With Obsessive-Compulsive Disorder
de Leeuw, A. S., van Megen, H. J. G. M., Kahn, R. S., & Westenberg, H. G. M. (2016) · European Psychiatry · doi:10.1016/j.eurpsy.2016.06.011 · Cited by 24
Efficacy of D‐cycloserine augmented brief intensive cognitive‐behavioural therapy for paediatric obsessive‐compulsive disorder: A randomised clinical trial
Farrell, L. J., Waters, A. M., Tiralongo, E., Mathieu, S., McKenzie, M., Garbharran, V., Ware, R. S., Zimmer‐Gembeck, M. J., McConnell, H., Lavell, C., et al. (2022) · Depression and Anxiety · doi:10.1002/da.23242 · Cited by 23
Treating OCD: what to do when first-line therapies fail
Castle, D. J., Bosanac, P., & Rossell, S. L. (2015) · Australasian Psychiatry · doi:10.1177/1039856215590027 · Cited by 23
Exploring the Maze of Cycloserine Conformers in the Gas Phase Guided by Microwave Spectroscopy and Quantum Chemistry
Alonso, E. R., Fusè, M., León, Í., Puzzarini, C., Alonso, J. L., & Barone, V. (2021) · The Journal of Physical Chemistry A · doi:10.1021/acs.jpca.1c00455 · Cited by 22
Shared social competence impairment: Another link between the obsessive-compulsive and autism spectrums?
Chasson, G. S., Timpano, K. R., Greenberg, J. L., Shaw, A. M., Singer, T., & Wilhelm, S. (2011) · Clinical Psychology Review · doi:10.1016/j.cpr.2011.02.006 · Cited by 24
Self-citation
D-cycloserine augmentation in behavioral therapy for obsessive-compulsive disorder: a meta-analysis
Yu, X., Xia, J., Du, Y., Han, J., & Liu, G. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s68994 · Cited by 18
Advances in the treatment of pediatric obsessive–compulsive disorder: rationale and design for the evaluation of D -cycloserine with exposure and response prevention
Mcguire, J. F., Lewin, A. B., GELLER, D. A., Brown, A., Ramsey, K. A., Mutch, J., Andrew Mittelman, B., Micco, J. A., Jordan, C., Wilhelm, S., et al. (2012) · Neuropsychiatry · doi:10.2217/npy.12.38 · Cited by 17
Self-citation
L’integrazione dei trattamenti nel disturbo ossessivo-compulsivo: conoscenze attuali e prospettive future
Albert, U., Barbaro, F., Aguglia, A., Maina, G., & Bogetto, F. (2012) · Rivista di psichiatria · doi:10.1708/1139.12553 · Cited by 16
Hoping for more: How cognitive science has and hasn't been helpful to the OCD clinician
Ouimet, A. J., Ashbaugh, A. R., & Radomsky, A. S. (2018) · Clinical Psychology Review · doi:10.1016/j.cpr.2018.04.003 · Cited by 18
Treating refractory obsessive-compulsive disorder: what to do when conventional treatment fails?
Franz, A. P., Paim, M. F., de Araújo, R. M. F., Rosa, V. D. O., Barbosa, Í. M., Blaya, C., & Ferrão, Y. A. (2013) · Trends in Psychiatry and Psychotherapy · doi:10.1590/s2237-60892013000100004 · Cited by 16
Combining Drug and Psychological Treatments for Obsessive- Compulsive Disorder: What is the Evidence, When and for Whom
Albert, U., Salvo, G. D., Solia, F., Rosso, G., & Maina, G. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867324666170712114445 · Cited by 16
Sudden gains in internet-based cognitive behavior therapy for obsessive-compulsive disorder
Hamdeh, A. A., Bjureberg, J., Lenhard, F., Hedman‐Lagerlöf, E., Flygare, O., Lundström, L., Ljótsson, B., Mataix‐Cols, D., Rück, C., & Andersson, E. (2018) · Journal of Obsessive-Compulsive and Related Disorders · doi:10.1016/j.jocrd.2018.12.005 · Cited by 15
A randomized controlled trial of cognitive remediation and d-cycloserine for individuals with bipolar disorder
Breitborde, N. J. K., Dawson, S. C., Woolverton, C. B., Dawley, D., Bell, E. K., Norman, K. R., Polsinelli, A. J., Bernstein, B., Mirsky, P., Pletkova, C., et al. (2014) · BMC Psychology · doi:10.1186/s40359-014-0041-4 · Cited by 16
Psychotherapy and medication management strategies for obsessive-compulsive disorder
Walsh, K. H., & McDougle (2011) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s13205 · Cited by 15
The Effect of d -Cycloserine on Subliminal Cue Exposure in Spider Fearful Individuals
Gutner, C. A., Weinberger, J. L., & Hofmann, S. G. (2012) · Cognitive Behaviour Therapy · doi:10.1080/16506073.2012.711770 · Cited by 13
Initial characterization of D-cycloserine for future formulation development for anxiety disorders
Kaushal, G., Ramirez, R., Alambo, D., Taupradist, W., Choksi, K., & Sirbu, C. (2011) · Drug Discoveries & Therapeutics · doi:10.5582/ddt.2011.v5.5.253 · Cited by 13
Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders
Katzman, M. A., Bleau, P., Blier, P., Chokka, P. R., Kjernisted, K. D., & Ameringen, M. V. (2021) · doi:10.32920/14638581 · Cited by 13
The Future of D-Cycloserine and Other Cognitive Modifiers in Obsessive- Compulsive and Related Disorders
Sulkowski, M. L., GELLER, D. A., Lewin, A. B., Murphy, T. K., Andrew Mittelman, B., A., B., Brown, A., A., B., & Storch, E. (2014) · Current Psychiatry Reviews · doi:10.2174/1573400510666140619224942 · Cited by 11
Obsessive–Compulsive Disorder
Murphy, T. K., Frazier, S., & Kim, S. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-252-6_10 · Cited by 11
Biological treatments for obsessive-compulsive and related disorders
Borue, X., Sharma, M., & Hudak, R. (2015) · Journal of Obsessive-Compulsive and Related Disorders · doi:10.1016/j.jocrd.2015.03.003 · Cited by 11
Evidence-Based Pharmacotherapy for Pediatric Obsessive-Compulsive Disorder and Chronic Tic Disorders
Nadai, A. S. D., Storch, E. A., Mcguire, J. F., Lewin, A. B., & Murphy, T. K. (2011) · Journal of Central Nervous System Disease · doi:10.4137/jcnsd.s6616 · Cited by 10
Cognitive Behavioral Therapy for Obsessive Compulsive Disorder
Al-Sharbati, Z. M., Al‐Sharbati, M. M., & Gupt, I. (2014) · InTech eBooks · doi:10.5772/57332 · Cited by 11
Efficacy of tDCS to enhance virtual reality exposure therapy response in acrophobia: A randomized controlled trial
Hui, H., Hong, A., Gao, J. J., Yu, J., & Wang, Z. (2024) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2024.01.027 · Cited by 8
d-Cycloserine-Augmented Behavior Therapy for Body Dysmorphic Disorder: A Preliminary Efficacy Trial
Weingarden, H. M., Mothi, S. S., Ladis, I., Hoeppner, S. S., Reese, H. E., Timpano, K. R., Siev, J., Rasmussen, J. L., Ragan, J. D., Dougherty, D. D., et al. (2019) · Cognitive Therapy and Research · doi:10.1007/s10608-019-10015-0 · Cited by 7
Self-citation
Cognitive-Behavior Therapy Outcomes for Obsessive-Compulsive Disorder: Exposure and Response Prevention
Wheaton, M. G., Schwartz, M. R., Pascucci, O., & Simpson, H. B. (2015) · Psychiatric Annals · doi:10.3928/00485713-20150602-05 · Cited by 7
A precision medicine approach to pharmacological adjuncts to extinction: A call to broaden research
King, G., Baker, K. D., Bisby, M. A., Chan, D., Cowan, C. S. M., Stylianakis, A. A., Zimmermann, K. S., & Richardson, R. (2019) · Psychopharmacology · doi:10.1007/s00213-018-4999-0 · Cited by 6
Isomerism of Cycloserine and Its Protonated Form
Fraschetti, C., Filippi, A., Borocci, S., Steinmetz, V., & Speranza, M. (2014) · ChemPlusChem · doi:10.1002/cplu.201400006 · Cited by 6
D-Cycloserine Augmented Treatment of Anxiety Disorders in Children and Adolescents: A Review of Preliminary Research
Byrne, S., Farrell, L. J., Storch, E. A., & Rapee, R. M. (2014) · Psychopathology Review · doi:10.5127/pr.033013 · Cited by 6
Augmenting Obsessive-Compulsive Disorder Treatment
Ressler, K. J., & ROTHBAUM, B. O. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.2116 · Cited by 6
Enhancing Exposure Therapy for PTSD Using d-Cycloserine
Burton, M. S., Youngner, C., McCarthy, A. J., Rothbaum, A. O., & ROTHBAUM, B. O. (2014) · Springer eBooks · doi:10.1007/978-1-4899-7522-5_18 · Cited by 5
Effects of D-cycloserine augmentation on cognitive behavioral therapy in patients with obsessive-compulsive disorder: A systematic review and meta-analysis
Gu, W., Storch, E. A., Zhao, Q., Xu, T., & Wang, Z. (2017) · Journal of Obsessive-Compulsive and Related Disorders · doi:10.1016/j.jocrd.2017.03.001 · Cited by 5
D-cycloserine nasal formulation development for anxiety disorders by using polymeric gels
Shin, Y., Kokate, R. A., Desai, V. S., Bhushan, A., & Kaushal, G. (2018) · Drug Discoveries & Therapeutics · doi:10.5582/ddt.2018.01017 · Cited by 5
D-Cycloserine for Treatment Nonresponders With Obsessive-Compulsive Disorder: A Case Report
Norberg, M. M., Gilliam, C. M., Villavicencio, A. L., Pearlson, G. D., & Tolin, D. F. (2011) · Cognitive and Behavioral Practice · doi:10.1016/j.cbpra.2011.05.002 · Cited by 6
Self-citation
Validation of a Chinese Version of the Obsessive Beliefs Questionnaire
Sun, L., Wang, J., Sun, H., Dong, Z., & Chasson, G. S. (2013) · Journal of Psychopathology and Behavioral Assessment · doi:10.1007/s10862-013-9395-9 · Cited by 4
Self-citation
Obsessive Compulsive Disorder
Murphy, T. K., Stewart, S. E., & Obregon, D. F. (2016) · Springer eBooks · doi:10.1007/978-1-4939-2528-5_10 · Cited by 6
The potential effect of d-cycloserine on the development of anxiety during exposure sessions in patients with agoraphobia
Pyrkosch, L., Lautenbacher, L. M., Mumm, J., Plag, J., Fehm, L., Fydrich, T., & Ströhle, A. (2024) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2024.10.018 · Cited by 3
Brazilian Research Consortium on Obsessive-Compulsive Spectrum Disorders guidelines for the treatment of adult obsessive-compulsive disorder. Part II: cognitive-behavioral therapy
de Mathis, M. A., Chacon, P., Boavista, R., de Oliveira, M. V. S., de Barros, P. M. F., Echevarria, M. A. N., Ferrão, Y. A., Vattimo, E. F. D. Q., Lopes, A. C., Torres, A. R., et al. (2023) · Brazilian Journal of Psychiatry · doi:10.47626/1516-4446-2023-3081 · Cited by 3
The effect of d-cycloserine on social anxiety treatment using a behavioral outcome measure and a postsession administration strategy.
Sheerin, C. M., Kozak, A. T., Hale, A. C., Ramesh, B. K., & Spates, C. R. (2016) · Behavior Analysis Research and Practice · doi:10.1037/bar0000054 · Cited by 3
Treatment of obsessive-compulsive disorder with frontopolar multifocal transcranial direct current stimulation and exposure and response prevention: A case Series
Adams, T. G., Rippey, C. S., Kelly, A. R., Gold, B. T., & Pittenger, C. (2021) · Brain stimulation · doi:10.1016/j.brs.2021.09.008 · Cited by 3
Slope of Change through D-Cycloserine Facilitation of Exposure Therapy in a Social Anxiety Population
Sheerin, C. M. (2013) · ScholarWorks - WMU (Western Michigan University) · Cited by 3
Novel approaches in treatment of pediatric anxiety
Park, J. M., & Geller, D. A. (2014) · F1000Prime Reports · doi:10.12703/p6-30 · Cited by 2
Intranasal Oxytocin Combined With Social Skills Training for Schizophrenia: An Add-on Randomized Controlled Trial
Saporta, L., Feldman, R., Levi, L. W., Davidson, M., Burshtein, S., Gur, R. C., Zagoory‐Sharon, O., Amiaz, R., Park, J., Davis, J. M., et al. (2024) · Schizophrenia Bulletin Open · doi:10.1093/schizbullopen/sgae022 · Cited by 2
L'integrazione dei trattamenti nel disturbo ossessivo-compulsivo: conoscenze attuali e prospettive future Combined treatments in obsessive-compulsive disorder: current knowledge and future prospects
Albert, U., Barbaro, F., Aguglia, A., Maina, G., & Bogetto, F. (2016) · Cited by 2
Introduction to the Special Issue
Mckay, D., & Storch, E. (2014) · Clinical Case Studies · doi:10.1177/1534650113504486
Exposure Techniques
Vorstenbosch, V., Newman, L., & Antony, M. M. (2013) · Wiley eBooks · doi:10.1002/9781118528563.wbcbt03 · Cited by 3
The Use of Glutamate Modulating Drugs in Obsessive Compulsive Disorder
MacMaster, F. P., & Rosenberg, D. R. (2010) · Child and Adolescent Psychopharmacology News · doi:10.1521/capn.2010.15.6.1 · Cited by 2
Electronic structure and conformational flexibility of d -cycloserine
Filippi, A., Fraschetti, C., Grandinetti, F., Speranza, M., Ponzi, A., Decleva, P., & Stranges, S. (2015) · Physical Chemistry Chemical Physics · doi:10.1039/c5cp01471a · Cited by 1
Obsessive‐Compulsive Disorder: Assessment and Treatment
Amitai Abramovitch, A., Elliott, C. M., Wilhelm, S., Steketee, G. S., & Wilson, A. C. (2014) · Wiley eBooks · doi:10.1002/9781118775349.ch51 · Cited by 1
Self-citation
D‐Cycloserine
Guastella, A. J., & Alvares, G. A. (2012) · Wiley eBooks · doi:10.1002/9781119945901.ch5 · Cited by 1
Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders
Katzman, M. A., Bleau, P., Blier, P., Chokka, P. R., Kjernisted, K. D., & Ameringen, M. V. (2021) · doi:10.32920/14638581.v1 · Cited by 1
Obsessive control and challenging tests. Experimental studies on neurobiological mechanisms in the pathogenesis and treatment of obsessive-compulsive disorder
de Leeuw, A. S. (2013) · Utrecht University Repository (Utrecht University)
Cognitive-Behavioral Therapy for Obsessive-Compulsive Disorder
Sassano-Higgins, S. A., Sapp, F., & Noppen, B. L. V. (2015) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.130207 · Cited by 1
Pharmacologic-Augmented Treatments
Schneider, S. C., & Storch, E. A. (2019) · Cambridge University Press eBooks · doi:10.1017/9781108235655.020
Literaturverzeichnis zu Voderholzer, Hohagen (Hrsg.): Therapie psychischer Erkankungen, 9. Auflage
(2013) · Elsevier eBooks · doi:10.1016/b978-3-437-24905-1.16001-0

Authors: Chasson, G. S., Buhlmann, U., Tolin, D. F., Rao, S. R., Reese, H. E., Rowley, T., Welsh, K. S., & Wilhelm, S.
Affiliations: Harvard University (US)
Humboldt-Universität zu Berlin (DE)
Yale University (US)
Corresponding author: Wilhelm, Sabine
ORCID: Chasson, Gregory S.
Buhlmann, Ulrike
Tolin, David F.
Rao, Sowmya R.
Reese, Hannah E.
Wilhelm, Sabine
Venue: Behaviour Research and Therapy
Publisher: Elsevier BV
Published: 2010-07
Volume: 48
Issue: 7
Pages: 675-679
ISSN: 0005-7967 (ISSN-L)
DOI: 10.1016/j.brat.2010.03.007
OpenAlex: W1990461673
Cited by: 106
References: 20
Citations by year: 2024: 4 · 2023: 2 · 2022: 1 · 2021: 4 · 2020: 1 · 2019: 6 · 2018: 6 · 2017: 8 · 2016: 7 · 2015: 10 · 2014: 19 · 2013: 19 · 2012: 6
FWCI: 12.96
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Behaviour Research and Therapy (publishedVersion)
PubMed (publishedVersion)
Topics: Social Sciences › Psychology › Clinical Psychology › Obsessive-Compulsive Spectrum Disorders
Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Social Sciences › Psychology › Clinical Psychology › Psychoanalysis and Psychopathology Research
Keywords: D-cycloserine, obsessive-compulsive disorder, exposure and response prevention, placebo comparison, treatment discontinuation, treatment costs, health care access
MeSH terms: Adult, Behavior Therapy, Combined Modality Therapy, Cycloserine, Female, Humans, Interview, Psychological, Male, Middle Aged, Obsessive-Compulsive Disorder, Psychiatric Status Rating Scales, Psychotropic Drugs, Self-Assessment, Time Factors, Treatment Outcome, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Need for speed: Evaluating slopes of OCD recovery in behavior therapy enhanced with d-cycloserine

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Citations

Cites

Cited by

Related

Metadata

Record

About these checks